Qiming Venture Partners — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Abogen is a biotechnology company developing mRNA-based therapeutics and vaccines, including an mRNA shingles vaccine and mRNA-encoded T-cell engagers for cancer such as B-cell non-Hodgkin lymphoma.
AI & Machine LearningBiotechDeep TechHealthtech
Bo Ying(Founder, Chairman and CEO)
Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalSoftBank Vision FundBoyu CapitalGL Ventures+7 more
Cornerstone Robotics (康诺思腾), founded in 2019, develops, manufactures, and sells high-end surgical robots for medical centers and healthcare providers.
HealthtechMedical DevicesRobotics
Samuel Au(Founder)inAlexis Cheng(Founder)Zerui Wang(Founder)
Co-investorsAlpha JWC VenturesGaorong VenturesK2VC
Dingdong Maicai is an online grocery retailer offering fresh food and groceries ordered via a mobile app, with fast delivery (as quick as 29 minutes) and no minimum order threshold.
ConsumerE-commerceFoodTechMiami Beach, US
Kim Perell(Manager)James Brennan(Manager)Liang Changlin(Founder)
Co-investorsCoatue ManagementGeneral AtlanticSoftBank Vision FundDST GlobalFortune Venture CapitalGaorong Ventures+2 more
BIT Invest, a flagship unit of BIT Group, offers investment solutions for cryptocurrency and digital asset holders, including structured products, fixed income instruments, and lending services secured by digital collateral.
Crypto & Web3Fintech
John Ge(Founder)inJihan Wu(Founder)in
Co-investorsBlockchain CoinvestorsFenbushi CapitalHash GlobalK3 VenturesParadigmStandard Crypto+10 more
Supermag manufactures magnetic levitation motors, fluid transport systems, and vacuum solutions for semiconductor, biopharmaceutical, chemical, and energy industries.
Advanced ManufacturingBiotechDeep TechHardwareSemiconductorsSuzhou, CN
Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.
BiotechHealthtechSeattle, US
Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)Andrew Scharenberg(Founder)Michael Jensen(Founder)Philip Low(Founder)Ryan Crisman(Founder)
Co-investorsMPM BioImpactDCVC BioQiming Venture Partners USASoftBank GroupColorado BioScience AssociationK2 HealthVentures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
















